A review on mPGES-1 inhibitors: From preclinical studies to clinical applications

被引:61
作者
Bergqvist, Filip [1 ]
Morgenstern, Ralf [2 ]
Jakobsson, Per-Johan [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, D2 01, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, Biochem Toxicol Unit, SE-17177 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Prostaglandin E-2; NSAIDs; Cyclooxygenase; Cancer; Inflammation; PROSTAGLANDIN-E SYNTHASE-1; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HYPERPLASTIC GASTRIC TUMORS; ACTIVATED RECEPTOR-GAMMA; CANCER-INDUCED ANOREXIA; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; E-2; SYNTHASE-1; GENETIC-DELETION; UP-REGULATION; PROINFLAMMATORY CYTOKINES;
D O I
10.1016/j.prostaglandins.2019.106383
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin E-2 (PGE(2)) is a lipid mediator of inflammation and cancer progression. It is mainly formed via metabolism of arachidonic acid by cyclooxygenases (COX) and the terminal enzyme microsomal prostaglandin E synthase-1 (mPGES-1). Widely used non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COX activity, resulting in decreased PGE(2) production and symptomatic relief. However, NSAIDs block the production of many other lipid mediators that have important physiological and resolving actions, and these drugs cause gastrointestinal bleeding and/or increase the risk for severe cardiovascular events. Selective inhibition of downstream mPGES-1 for reduction in only PGE(2) biosynthesis is suggested as a safer therapeutic strategy. This review covers the recent advances in characterization of new mPGES-1 inhibitors in preclinical models and their future clinical applications.
引用
收藏
页数:11
相关论文
共 201 条
[1]   Role of microsomal prostaglandin E synthase-1 in the facilitation of angiogenesis and the healing of gastric ulcers [J].
Ae, Takako ;
Ohno, Takashi ;
Hattori, Youichiro ;
Suzuki, Tatsunori ;
Hosono, Kanako ;
Minamino, Tsutomu ;
Sato, Takehito ;
Uematsu, Satoshi ;
Akira, Shizuo ;
Koizumi, Wasaburo ;
Majima, Masataka .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 299 (05) :G1139-G1146
[2]   Microsomal prostaglandin E synthase-1 is induced in alzheimer's disease and its deletion mitigates alzheimer's disease-like pathology in a mouse model [J].
Akitake, Yoshiharu ;
Nakatani, Yoshihito ;
Kamei, Daisuke ;
Hosokawa, Masato ;
Akatsu, Hiroyasu ;
Uematsu, Satoshi ;
Akira, Shizuo ;
Kudo, Ichiro ;
Hara, Shuntaro ;
Takahashi, Mitsuo .
JOURNAL OF NEUROSCIENCE RESEARCH, 2013, 91 (07) :909-919
[3]  
[Anonymous], EBIOMEDICINE
[4]  
[Anonymous], BIOORG MED CHEM LETT
[5]  
[Anonymous], INHIBITION MPGES 1 T
[6]  
[Anonymous], FREE RADIC RES
[7]   Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation [J].
Arhancet, Graciela B. ;
Walker, Daniel P. ;
Metz, Sue ;
Fobian, Yvette M. ;
Heasley, Steven E. ;
Carter, Jeffrey S. ;
Springer, John R. ;
Jones, Darin E. ;
Hayes, Michael J. ;
Shaffer, Alexander F. ;
Jerome, Gina M. ;
Baratta, Michael T. ;
Zweifel, Ben ;
Moore, William M. ;
Masferrer, Jaime L. ;
Vazquez, Michael L. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (04) :1114-1119
[8]   J Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension [J].
Avendano, M. S. ;
Martinez-Revelles, S. ;
Aguado, A. ;
Simoes, M. R. ;
Gonzalez-Amor, M. ;
Palacios, R. ;
Guillem-Llobat, P. ;
Vassallo, D. V. ;
Vila, L. ;
Garcia-Puig, J. ;
Beltran, L. M. ;
Alonso, M. J. ;
Cachofeiro, M. V. ;
Salaices, M. ;
Briones, A. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (09) :1541-1555
[9]   mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress [J].
Avendano, Maria S. ;
Garcia-Redondo, Ana B. ;
Zalba, Guillermo ;
Gonzalez-Amor, Maria ;
Aguado, Andrea ;
Martinez-Revelles, Sonia ;
Beltran, Luis M. ;
Camacho, Mercedes ;
Cachofeiro, Victoria ;
Alonso, Maria J. ;
Salaices, Mercedes ;
Briones, Ana M. .
HYPERTENSION, 2018, 72 (02) :492-502
[10]   15-hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer [J].
Backlund, MG ;
Mann, JR ;
Holla, VR ;
Buchanan, FG ;
Tai, HH ;
Musiek, ES ;
Milne, GL ;
Katkuri, S ;
DuBois, RN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3217-3223